Delivery Order 75F40120D00027-75F40120F19001
Award Date 9/30/20
Potential Completion Date 9/29/21
Potential Value $2.7M
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Time and Materials
Place of Performance
Falls Church, VA 22042, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
4
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services Food and Drug Administration awarded a $5,273,171.50 delivery order contract to Iqvia Government Solutions Inc. to conduct surveillance activities for the safety and effectiveness of biologics. This contract is part of the BEST Initiative, a larger indefinite-delivery, indefinite-quantity (IDIQ) contract vehicle for data tools and infrastructure to support surveillance of biologics. Iqvia Government Solutions is a for-profit organization that has...
- This is a delivery order awarded to Iqvia Government Solutions Inc. under the Biologics Effectiveness and Safety (BEST) Initiative #3: Data Sources for Surveillance of Biologics indefinite delivery, indefinite quantity (IDIQ) contract with the Food and Drug Administration (FDA). The $17,498,031.84 award will provide data sources to conduct surveillance of biologics, covering tens of millions of patients from insurers, payers, and providers. The BEST Initiative IDIQ is valued at $50 million and...
- This is a $4,415,338.31 delivery order contract awarded by the Center for Biologics Evaluation and Research (CBER) of the Food and Drug Administration (FDA) to Iqvia Government Solutions Inc., a prominent for-profit healthcare data and analytics provider. The contract is for the CBER's Biologics Effectiveness and Safety (BEST) Initiative #3, which focuses on utilizing healthcare data sources for surveillance of biologics (BEST 3). The contract is a time and materials type with a period of...
- This is a $2,442,983.29 time-and-materials contract awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to Iqvia Government Solutions Inc., a for-profit provider of healthcare data, analytics, and related services to federal agencies. The contract is for the Biologics Effectiveness and Safety (BEST) Initiative, which involves blood and blood products safety surveillance. No set-aside was used. Iqvia has held several past and current IDIQ contracts with the...
- The Department of Health and Human Services Food and Drug Administration awarded a $5.1 million delivery order against the BEST Initiative - Data Sources for Surveillance of Biologics master IDIQ contract. The order is for BIOLOGICS EFFECTIVENESS AND SAFETY (BEST) INITIATIVE #3: DATA SOURCES FOR SURVEILLANCE OF BIOLOGICS, and will be performed by The Lewin Group, Inc., doing business as Lewin Group Inc., a subsidiary of UnitedHealth Group Incorporated. Work will take place in Mosby, Virginia...
- The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $13.2 million delivery order contract to International Business Machines Corporation (IBM) under the Biologics Effectiveness and Safety (BEST) Initiative - Data Tools and Infrastructure for Surveillance of Biologics indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle. The contract calls for IBM to provide data, tools, and infrastructure to support HHS FDA's BEST Initiative for surveillance of...
- This is a $5,967,111.25 delivery order contract awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to IQVIA Government Solutions Inc., a provider of healthcare data, analytics, and related services to U.S. federal agencies. The contract was awarded under the FDA's BEST Initiative - Data Tools and Infrastructure for Surveillance of Biologics indefinite delivery, indefinite quantity (IDIQ) contract vehicle. The contract is for the development and...
- The Department of Health and Human Services Food and Drug Administration awarded a $2,461,558.38 Definitive Contract on a Time and Materials basis to Iqvia Government Solutions Inc., a healthcare data and analytics provider, to develop new, innovative methods for automation of blood product adverse event reporting under the Biologics Effectiveness and Safety (BEST) Initiative. This contract does not have a set-aside designation. Iqvia provides a range of healthcare data and analytics services to...
- The Food and Drug Administration (FDA) awarded a $24,583,221.15 delivery order contract to The Lewin Group, Inc. (a subsidiary of UnitedHealth Group Incorporated), to support the BIOLOGICS EFFECTIVENESS AND SAFETY (BEST) INITIATIVE #3: DATA SOURCES FOR SURVEILLANCE OF BIOLOGICS. This contract is a task order under the $50 million BEST Initiative - Data Sources for Surveillance of Biologics indefinite-delivery/indefinite-quantity (IDIQ) contract, which provides longitudinal data sources needed to...
- This federal contract was awarded by the Department of Health and Human Services Food and Drug Administration to the International Business Machines Corporation (IBM) on September 24, 2019. The $5,622,942.08 time and materials contract is a delivery order under the BEST Initiative - Data Tools and Infrastructure for Surveillance of Biologics master IDIQ contract vehicle. The objective is for IBM to conduct surveillance activities to assess the safety and effectiveness of biologics. This work...
- 75F40120D00027Indefinite Delivery Contract
- 75F40120D00027-75F40120F19001Delivery Order
The Department of Health and Human Services Food and Drug Administration awarded a $2.68 million delivery order against the BEST Initative - Data Sources For Surveillance of Biologics master IDIQ to Iqvia Government Solutions Inc. The one-year order, with a period of performance from September 2020 through September 2021, will provide products and services in support of the BIOLOGICS EFFECTIVENESS AND SAFETY (BEST) INITIATIVE #3: DATA SOURCES FOR SURVEILLANCE OF BIOLOGICS effort. Under a time and materials pricing structure, Iqvia will leverage data sources to support the FDA's post-market surveillance of biologics as part of the Coronavirus COVID-19 National Interest Action. No set aside designation was specified.
Generated 12/25/23, 5:47 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Supplemental Agreement for work within scope | $151.2k | 8/30/21 | |
| Not listed | Not listed | $2.5m | 9/30/20 |